QNCX Stock Analysis: Buy, Sell, or Hold?
QNCX - Quince Therapeutics, Inc. Common Stock
$33.93
1.82 (5.67%)
▲
5d:
-0.32%
30d:
+85.61%
90d:
+3071.03%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When QNCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: QNCX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: QNCX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: QNCX is currently trading at $33.93, which is considered extended relative to its 30-day fair value range of $19.85 to $32.39.
Technical Outlook: Technically, QNCX is in a strong uptrend. Immediate support is located at $29.68, while resistance sits at $35.41. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: QNCX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $79.75 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNCX is in a strong uptrend. Immediate support is located at $29.68, while resistance sits at $35.41. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: QNCX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $79.75 (+148.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.85 -
$32.39
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.7%)
- BULLISH: Trading 148.4% below Wall St target ($79.75)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.85 -
$32.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$29.68
Resistance Level
$35.41
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.86
Wall Street Target
$79.75
(+148.4%)
Share & Embed Analysis
Last updated: August 24, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
